Biochemistry and Molecular Biology Seminar Series presents Estella Newcombe, PhD Oration

Wednesday, 25 May, 2016 - 12:00 to 13:00

“Understanding the biology of Huntington’s disease via the pathogenic hunting tin monomer” 

Bio21 Big Picture Seminar: CSL and the Australian Biomedical Research Sector – Past, Present and Future

Thursday, 2 June, 2016 - 17:30

Dr Andrew Nash, Senior Vice President, Research, CSL Limited is presenting the Bio21 Big Picture Seminar, 2nd June 2016

Professor Ary Hoffmann elected to the American Academy of Arts and Sciences

Professor Ary Hoffmann from the School of BioSciences and Bio21 Institute at the University of Melbourne has been elected into the American Academy of Arts and Sciences as a Foreign Honorary Member — Evolutionary and Population Biology, and Ecology.

Move it or lose it: exploiting genetic diversity to fight extinction

By Dr Ben Phillips, Dr Andrew Weeks and Professor Ary Hoffmann, School of Biosciences, University of Melbourne.

Media Release: CSL Announces $25 million Centenary Fellowship Program

CSL’s Chief Executive Officer, Mr Paul Perreault, at the CSL Centenary Celebration Gala announcing the establishment of a new flagship $25 million fellowship program for early stage and translational research in Australia

SARTATE trial results to be presented at the upcoming 2016 SNMMI Meeting

Clarity’s strong collaboration with Associate Professor Paul Donnelly at the School of Chemistry and Bio21 Institute, University of Melbourne enabled the initial manufacture and development of the product that was then translated into the clinic in the recently completed SARTATE™ proof-of-concept clinical trial for neuroendocrine tumours (NETs).

Media Release: Flexi is sexy for malaria parasite

Human red blood cells have remarkable abilities, allowing them to bend, extend and ‘squeeze’ through capillaries as they circulate through the blood stream.


Subscribe to Bio21 Molecular Science & Biotechnology Institute RSS